Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
HOWL
#3650
Werewolf Therapeutics, Inc. Common Stock
0.6
0
-1.64%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
-1.64%
Changement Mensuel
-11.76%
Evolution sur 6 mois
-55.88%
Changement Annuel
-49.15%
Clôture Précédente
0.6
1
Open
0.6
0
Bid
Ask
Low
0.6
0
High
0.6
0
Volume
3
Marchés
Actions des Marchés US
Soins de Santé
HOWL
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
Nouvelles
Werewolf Therapeutics explora venda e alternativas estratégicas
Werewolf Therapeutics explores sale and strategic alternatives
Ações da Werewolf Therapeutics caem após anúncio de redução de 64% da força de trabalho
Werewolf Therapeutics stock falls after announcing 64% workforce reduction
Werewolf Therapeutics recebe notificação da Nasdaq por deficiência no preço mínimo de oferta
Werewolf Therapeutics receives Nasdaq notice for minimum bid price deficiency
Diretor da Werewolf Therapeutics, Luke Evnin, vende ações no valor de US$ 20.942
Evnin Luke, Werewolf Therapeutics director, sells $20,942 in Howl stock
Evnin Luke vende ações da Werewolf Therapeutics (HOWL) por US$ 53.533
Evnin Luke sells Werewolf Therapeutics (HOWL) shares for $53,533
Diretor Luke Evnin vende ações da Werewolf Therapeutics (HOWL) por US$ 45.882
Evnin Luke sells Werewolf Therapeutics (HOWL) stock for $45,882